Table 1:

Subject population demographics and AUD pharmacotherapy receipt by characteristics

Characteristic	Total sample			Received pharmacotherapy
	N	%		No			Yes
				N	%		N	%
All subjects	123,355	100		119,281	96.7		4074	3.3
Sex
Male	79,571	64.5		77,279	97.1		2,292	2.9
Female	43,784	35.5		42,002	95.9		1,782	4.1
Age, years
18-34	5,331	4.3		5,308	99.6		23	0.4
35-44	50,858	41.2		49,746	97.8		1,112	2.2
45-54	21,770	17.7		20,756	95.3		1,014	4.7
55-65	26,281	21.3		25,155	95.7		1,126	4.3
>65	19,115	15.5		18,316	95.8		799	4.2
Provider specialty*
Primary care physician (PMD)	13,959	11.3		13,217	94.7		742	5.3
Primary care NP	557	0.45		527	94.6		30	5.4
Primary care PA	276	0.22		260	94.2		16	5.8
Psychiatry MD	7,928	6.4		7,416	93.5		512	6.5
Psychiatry NP	122	0.10		113	92.6		9	7.4
Psychologist	2,941	2.4		2,840	96.6		101	3.4
Addiction Treatment Specialist**	11,069	9.0		10,622	96.0		447	4.0

^*Includes a subsample of subjects seen in selected settings of interest (N=36,852)

^**Compromised of medical and non-medical counselors who focus on SUDs, including “Mental Health/Chemical Dependency not elsewhere classified”, “Mental Health facilities”, “Chemical Dependency Treatment Center”, “Mental Health/Chemical Dependency Day Care”, or “Residential Treatment Center”).